QUIA PHARMA
0,006
SEK
-6,06 %
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-6,06%
-42,59%
-40,95%
-78,98%
-83,11%
-91,8%
-99,96%
-100%
-100%
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Læs mereMarkedsværdi
10,44 mio. SEK
Aktieomsætning
25,12 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
12.2
2025
Ekstraordinær generalforsamling '25
26.2
2025
Årsrapport '24
ViserAlle indholdstyper
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools